Brexucabtagene Autoleucel,Axicabtagene Ciloleucel,Cyclophosphamide,Fludarabine
Gilead
['lymsm', 'bendamustine', 'brexu-cel']
congress|#asco23 swetha kambhampati describes real-world outcomes of brexu-cel post btk inhibitor, bendamustine, autohct and prior lines of therapy. outcomes were consistent regardless of prior clinical characteristics #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm